On July 16, Roche announced a mobile blood gas analyzer, the cobras b 123 POC system. The device, to be used for hospital point-of-care settings, virtually eliminates the introduction of blood clots.
A patented thick-film sensor and broad assay menu that includes lactate leads to fast turnaround for 15 critical-care blood gas and electrolyte tests. It’s mobile cart is capable of functioning in a variety of locations, from patient floor to intensive floor. The cobras b 123 POC system does not require refrigeration. In addition, the incorporation of removable smart chips allows for transferring between devices, which helps limit material and labor costs.
"The addition of the cobas b 123 POC system to our blood gas analyzer portfolio enables hospitals to provide lab-like accuracy for blood gas testing at the point of care, while reducing their potential maintenance requirements," said Joe Crowley, senior vice president, Professional Diagnostics-Hospital, at Roche Diagnostics Corporation. "As a result, respiratory therapists and other caregivers can spend more of their time focusing on patients and their needs."
